The company will broadcast a live webcast of its earnings conference call starting at 8 a.m. Central time. Shareholders and analysts can access the session through the investor relations portal at investors.abbvie.com. For those unable to attend the live presentation, an archived version of the call will be published on the same website later that day.

AbbVie continues to maintain its focus on therapeutic areas including immunology, neuroscience, and oncology, alongside its Allergan Aesthetics portfolio. The upcoming session serves as a primary update on the company’s progress in delivering medical solutions across these sectors.